Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Immune Intervention Reduces β-Cell Death in Type 1 Diabetes
Improvement in C-peptide responses seen with teplizumab; associated with decreased β-cell death
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

April 18, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

One in 20 U.S. Adults a Victim of Diagnostic Errors

Patient-Clinician Relationship Impacts Health Care Outcomes CME

GLP-1 Slows Hypoglycemia-Induced Gastric Emptying CME

Educator Discusses Key Issues for Future Doctors to Consider

Diabetes-Related Complications Declined, 1990 to 2010

Graves Disease Incidence Varies by Race